Figure 3.
A 64-year-old male patient with NSCLC in treatment with pembrolizumab (anti-PD-L1 monoclonal antibody). Axial chest CT shows pneumonitis characterized by peri-bronchial confluent parenchymal consolidation in the right lung in association with bilateral ground-glass opacities. NSCLC, non-small cell lung cancer.